[Federal Register Volume 62, Number 37 (Tuesday, February 25, 1997)] [Rules and Regulations] [Page 8372] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-4516] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES 21 CFR Part 529 Certain Other Dosage Form New Animal Drugs; Salicylic Acid; Technical Amendment AGENCY: Food and Drug Administration, HHS. ACTION: Final rule; technical amendment. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations concerning the use of salicylic acid to correct a certain typographical error. This action is being taken to clarify and improve the accuracy of the regulations. EFFECTIVE DATE: February 25, 1997. FOR FURTHER INFORMATION CONTACT: David L. Gordon, Center for Veterinary Medicine, Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-594-1737. SUPPLEMENTARY INFORMATION: FDA has found an error concerning the amount of salicylic acid per dose. In 21 CFR 529.2090(a)(1) that error has been incorporated into the agency's animal drug regulations. FDA is correcting this error. The approved concentration is 0.55 grain of salicylic acid per dose, not 0.55 gram of salicylic acid. List of Subjects in 21 CFR Part 529 Animal drugs. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 529 is amended as follows: PART 529--CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 529 continues to read as follows: Authority: Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b). Sec. 529.2090 [Amended] 2. Section 529.2090 Salicylic acid is amended in paragraph (a)(1) by removing the word ``gram'' and by adding in its place the word ``grain''. Dated: January 31, 1997. Robert C. Livingston, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. 97-4516 Filed 2-24-97; 8:45 am] BILLING CODE 4160-01-F